Author

R. D. Head

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell-cell communication· 1

Frequent Co-Authors

A. C. M. Boon· 1 shared A. Collins· 1 shared A. Dusso· 1 shared A. E. Riek· 1 shared A. L. Bailey· 1 shared A. Sheikh· 1 shared B. A. Rosa· 1 shared B. Tumala· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. C. M. Boon

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Embryonic Vitamin D Deficiency Programs Hematopoietic Stem Cells to Induce Type 2 Diabetes

C. Bernal-Mizrachi, J. Oh, A. E. Riek, K. T. Bauerle, A. Dusso, K. McNerney, R. Barve, I. Darwech, J. Sprague, C. Moynihan, R. M. Zhang, T. Wang, X. Xing, D. Li, R. D. Head, , M. S. Sands

The paper shows that embryonic vitamin D deficiency in HSCs leads to diabetes in mice by altering epigenetic pathways and macrophage function.

bioRxiv · Sep 8, 2022Physiology

Enterotoxigenic Escherichia coli heat-labile toxin drives enteropathic changes in small 1intestinal epithelia

A. Sheikh, B. Tumala, T. J. Vickers, J. C. Martin, B. A. Rosa, S. Sabui, R. D. Simoes, M. Mitreva, C. Storer, E. Tyksen, R. D. Head, W. Beatty, H. M. Said, J. M. Fleckenstein

This study shows that ETEC heat-labile toxin causes long-term intestinal damage beyond diarrhea, affecting nutrient absorption and growth in mice.

bioRxiv · Aug 24, 2022 · PreprintMicrobiology

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection

E. S. Winkler, P. Gilchuk, J. Yu, A. L. Bailey, R. E. Chen, S. J. Zost, H. Jang, Y. Huang, J. D. Allen, J. B. Case, R. E. Sutton, R. H. Carnahan, T. L. Darling, A. C. M. Boon, M. Mack, , M. Diamond

This study shows that neutralizing antibodies against SARS-CoV-2 need intact Fc functions and monocytes for optimal therapeutic protection in animal models.

bioRxiv · Dec 28, 2020Immunology